Erythropoietin receptor mutations and Olympic glory.
Longmore
G D
GD
D000818:Animals; D002478:Cells, Cultured; D015672:Erythroid Precursor Cells / Q000187:drug effects / Q000378:metabolism; D004921:Erythropoietin / Q000502:physiology* / Q000627:therapeutic use; D017079:Exercise Tolerance / Q000502:physiology*; D005799:Genes, Dominant; D006801:Humans; D051379:Mice; D005810:Multigene Family; D009154:Mutation; D010100:Oxygen / Q000097:blood; D011086:Polycythemia / Q000235:genetics*; D017467:Receptors, Erythropoietin / Q000235:genetics* / Q000502:physiology; D015375:Receptors, Interleukin-2 / Q000235:genetics; D011994:Recombinant Proteins / Q000378:metabolism; D016511:Severe Combined Immunodeficiency / Q000235:genetics; D015398:Signal Transduction; D013177:Sports
D017467:Receptors, Erythropoietin; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins; D004921:Erythropoietin; D010100:Oxygen